Introduction
Seizure aggravation by antiepileptic drugs (AEDs) is increasingly recognized as a common problem, particularly in idiopathic generalized epilepsy (IGE). Benzodiazepines (BZDs) are one type of the main AEDs, especially in the treatment of status epilepticus. Paradoxical worsening of seizures associated with BZD is uncommon and most reports are among pediatric patients [1] [2] [3] . We report the case of an adult epilepsy patient with simple partial seizures that were aggravated or induced by BZDs.
Case report
A 31-year-old woman presented with a 12-year history of recurrent episodes of involuntary jerky movements of her left leg occurring in clusters before her initial visit to our hospital. She first noticed symptoms at the age of 19. The first two episodes occurred during sleep and lasted for 20 and 40 min, respectively. The third and fourth episodes developed after she underwent sedative endoscopic examinations with intravenous midazolam. In both episodes, she woke up from sedation due to the jerky movements of her left leg. These movements lasted for 30 min and disappeared. However, the jerky movements recurred on that night and continued for 3 h before spontaneous resolution. Afterwards, she became reluctant to receive a sedative endoscopy and underwent two non-sedated endoscopic examinations. At those times, she experienced no abnormal movements. The fifth episode also occurred during sleep and persisted for 3 h; the patient visited the emergency center of a nearby hospital. After administration of intravenous midazolam, the jerky leg movements immediately worsened and lasted for 4 more hours. One month later, the patient visited our epilepsy clinic. The neurologic examination was normal. The brain MRI and routine EEG were unremarkable. No AED was initiated.
Four months later, a sixth episode developed during sleep but resolved spontaneously 15 min later. In the afternoon of the same day, the symptom reappeared and continued for 6 h, leading the patient to visit the emergency department of our hospital. Continuous video-EEG monitoring was performed with EMG surface electrodes placed on the left tibialis anterior muscle. The patient showed brief jerky movements of the left leg, involving mainly the proximal part, with hip internal rotation and knee flexion. The EEG showed intermittent sharp waves in the bilateral fronto-centro-parietal regions, particularly in the Cz electrode (Fig. 1A) . The jerky movements were preceded by these sharp waves. The initial frequency was approximately 0.1-0.2 Hz, and the EMG duration was 500-700 ms. Intravenous lorazepam was given as two separate 2 mg doses. The jerky movements of the left leg worsened in both frequency and amplitude, with intermittent involvement of the left arm although these seizures did not evolve to secondarily generalized tonic-clonic seizures. The concomitant EEG showed more frequent sharp waves with increased amplitude in the same region (Fig. 1B) and later showed prolonged sharply formed rhythmic delta activities in the right hemisphere associated with prolonged jerky movements (Fig. 1C & Video 1) . The symptom did not spontaneously subside for 45 min, and then intravenous loading of phenytoin was administered over 40 min. The jerky movements and the epileptiform EEG discharges gradually disappeared. Before lorazepam was administered, 99mTc-HMPAO SPECT was performed during the recurrent jerky movements of the left leg. An analysis of SISCOM revealed significantly increased cerebral blood flow in the right mesial frontal area, corresponding to the primary motor cortex of the left leg ( Fig. 2A) . Ictal hyperperfusion of subtracted SPECT was considered significant only when the regional cerebral blood flow difference in each pixel of brain SPECT images between ictal and interictal states was greater than two standard deviations of the distribution of the subtraction pixel intensities. Although carefully re-inspected, the MRI was unremarkable in the same area (Fig. 2B) .
A long-term AED treatment was recommended. However, the patient did not want to receive any AEDs because of concerns about pregnancy. We asked her not to take any BZDs for any reason. The symptom did not recur in the following 10 months.
Discussion
Paradoxical aggravation of seizures associated with AEDs is reported mostly in IGE. Certain narrow spectrum AEDs, such as carbamazepine, have long been known to aggravate absence, atypical absence, or myoclonic seizures. Here, we reported an unusual case of a drug-naïve patient who experienced aggravation or induction of focal motor seizures after intravenous BZD administration. Although there have been several case reports of seizure aggravation with BZDs, most cases described aggravation of generalized (mainly tonic) seizures in children with LennoxGastaut syndrome and in preterm neonates or precipitation of induced tonic-like microseizures in children with West syndrome [ [1] [2] [3] . All the reported cases in literature were taking baseline AED therapy which is different from the present case.
It is uncertain why the administration of intravenous BZDs can paradoxically aggravate seizures; many hypotheses have been proposed in previous reports. Some authors suggested that BZDs may cause transient decreases in cerebral blood flow or level of consciousness and contribute to seizure worsening [2] . Others thought it might be part of a general vulnerability to changes in inhibitory control mechanisms rather than a specific effect of the drug [1] . BZDs are effective AEDs, binding to g-aminobutyric acid A (GABA A ) receptors and enhancing GABA-mediated inhibitory neurotransmission. Recently, the dysmature cerebral developmental hypothesis in focal cortical dysplasia (FCD) suggested that neurons and networks may have immature cellular and synaptic properties, including depolarizing GABA-mediated neurotransmission due to high intracellular chloride concentration [4] . This might explain aggravation or induction of seizures after BZD administration in our patient, who might have MRI-negative FCD.
To our knowledge, aggravation of seizures associated with BZDs has been not reported in adults. We cannot completely exclude the possibility that the aggravation or induction of seizures related to BZD administration in our patient may reflect spontaneous fluctuation. However, considering the previous history of recurrent aggravation or induction of seizures after BZDs administration and our documentation by video EEG monitoring, it is highly plausible that our patient's seizures were aggravated or induced by BZD administration. Careful history analysis and review may be important for secondary prevention of seizure aggravation in some patients.
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